1. ScholarBank@NUS

Wee Joo Chng

rp04705

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Wee Joo Chng
Variants
Chng W.J
Chng, W.J.
Chng W.-J.
Wee Joo Chng
Chng, W.-J.
 
Main Affiliation
 
Faculty
 
Email
mdccwj@nus.edu.sg
 
Other emails
 

Publications

Refined By:
Department:  OFFICE OF THE DEPUTY PRESIDENT(RES&TECH)

Results 41-60 of 183 (Search time: 0.013 seconds).

Issue DateTitleAuthor(s)
4123-Apr-2020Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myelomaGoldschmidt, Hartmut; Dimopoulos, Meletios A; Rajkumar, S Vincent; Weisel, Katja C; Moreau, Philippe; Chng, Wee-Joo ; Mikala, Gabor; Cavo, Michele; Ramasamy, Karthik; Suryanarayan, Kaveri; Teng, Zhaoyang; Labotka, Richard; Victoria Mateos, Maria
4210-Jun-2020Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study-Asian Subgroup AnalysisHuang, Shang-Yi; Yoon, Sung-Soo; Shimizu, Kazuyuki; Chng, Wee Joo ; Chang, Cheng-Shyong; Wong, Raymond Siu-Ming; Gao, Seasea; Wang, Yang; Gordon, Steve W; Glennane, Anthony; Min, Chang-Ki
431-Jan-2021Determinants of response to daratumumab in Epstein-Barr virus-positive natural killer and T-cell lymphomaMustafa, Nurulhuda ; Nee, Adina Huey Fang ; Chooi, Jing Yuan ; Toh, Sabrina Hui Min ; Chung, Tae-Hoon ; Selvarajan, Viknesvaran ; Fan, Shuangyi ; Ng, Siok Bian ; Poon, Michelle ; Chan, Esther ; Lee, Joanne; Chee, Yen Lin ; Jeyasekharan, Anand D ; Zhou, Longen; Yang, Jennifer; Chng, Wee Joo 
442020Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myelomaDimopoulos, M.A.; Jakubowiak, A.J.; McCarthy, P.L.; Orlowski, R.Z.; Attal, M.; Bladé, J.; Goldschmidt, H.; Weisel, K.C.; Ramasamy, K.; Zweegman, S.; Spencer, A.; Huang, J.S.Y.; Lu, J.; Sunami, K.; Iida, S.; Chng, W.-J. ; Holstein, S.A.; Rocci, A.; Skacel, T.; Labotka, R.; Palumbo, A.; Anderson, K.C.
453-Nov-2011Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphomaNg, Siok-Bian ; Yan, Junli ; Huang, Gaofeng ; Selvarajan, Viknesvaran; Tay, Jim Liang-Seah; Lin, Baohong; Bi, Chonglei; Tan, Joy; Kwong, Yok-Lam; Shimizu, Norio; Aozasa, Katsuyuki; Chng, Wee-Joo 
46Apr-2012Effect of dasatinib against thyroid cancer cell lines in vitro and a xenograft model in vivoChan, D.; Tyner, J.W.; Chng, W.J. ; Bi, C.; Okamoto, R.; Said, J.; Ngan, B.D.; Braunstein, G.D.; Koeffler, H.P. 
471-Sep-2021Effective Killing of Acute Myeloid Leukemia by TIM-3 Targeted Chimeric Antigen Receptor T CellsLee, Wen-Hsin Sandy; Ye, Zhiyong; Cheung, Alice MS; Goh, YP Sharon; Oh, Hsueh Ling Janice; Rajarethinam, Ravisankar; Yeo, Siok Ping; Soh, Mun Kuen; Li Chan, Esther Hian; Tan, Lip Kun; Tan, Soo-Yong ; Chuah, Charles ; Chng, Wee Joo ; Connolly, John E; Wang, Cheng-I
481-Feb-2012Engineering the First Chimeric Antibody in Targeting Intracellular PRL-3 Oncoprotein for Cancer Therapy in MiceGuo, Ke; Tang, Jing Ping ; Jie, Li; Al-Aidaroos, Abdul Qader O; Hong, Cheng William; Tan, Cheng Peow Bobby; Park, Jung Eun; Varghese, Leyon; Feng, Zhiwei; Zhou, Jianbiao; Chng, Wee Joo ; Zeng, Qi 
492009Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AMLZhou, J. ; Bi, C.; Janakakumara, J.V. ; Liu, S.-C.; Chng, W.-J. ; Tay, K.-G. ; Poon, L.-F. ; Xie, Z. ; Palaniyandi, S. ; Chen, C.-S. ; Yu, H. ; Glaser, K.B.; Albert, D.H.; Davidsen, S.K.
5025-Aug-2020Epigenetic silencing of long non-coding RNABM742401in multiple myeloma: impact on prognosis and myeloma disseminationLi, Zhenhai; Kumar, Shaji; Jin, Dong-Yan; Calin, George A; Chng, Wee-Joo ; Siu, Kam-Leung; Poon, Ming-Wai; Chim, Chor Sang
512019Epigenetic silencing of miR-340-5p in multiple myeloma: Mechanisms and prognostic impactLi, Z.; Wong, K.Y.; Calin, G.A.; Chng, W.-J. ; Chan, G.C.-F.; Chim, C.S.
521-Feb-2018Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changesNg, Siok-Bian ; Chung, Tae-Hoon; Kato, Seiichi; Nakamura, Shigeo; Takahashi, Emiko; Ko, Young-Hyeh; Khoury, Joseph D; Yin, C Cameron; Soong, Richie; Jeyasekharan, Anand D ; Hoppe, Michal Marek; Selvarajan, Viknesvaran; Tan, Soo-Yong; Lim, Soon-Thye; Ong, Choon-Kiat ; Nairismagi, Maarja-Liisa; Maheshwari, Priyanka ; Choo, Shoa-Nian ; Fan, Shuangyi ; Lee, Chi-Kuen ; Chuang, Shih-Sung; Chng, Wee-Joo 
533-Aug-2015Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorder in children and young adults has similar molecular signature to extranodal nasal natural killer/T-cell lymphoma but shows distinctive stem cell-like phenotypeNg, Siok-Bian ; Ohshima, Koichi; Selvarajan, Viknesvaran ; Huang, Gaofeng ; Choo, Shoa-Nian ; Miyoshi, Hiroaki; Shimizu, Norio; Reghunathan, Renji ; Chua, Hsin-Chieh ; Yeoh, Allen Eng-Juh ; Thuan-Chong, Quah ; Koh, Liang-Piu ; Tan, Poh-Lin ; Chng, Wee-Joo 
542016Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: A role for MARCKS in acquired resistance to proteasome inhibitorsFranke, N.E; Kaspers, G.L; Assaraf, Y.G; Meerloo, J; Niewerth, D; Kessler, F.L; Poddighe, P.J; Kole, J; Smeets, S.J; Ylstra, B; Bi, C; Chng, W.J ; Horton, T.M; Menezes, R.X; Musters, R.J.P; Zweegman, S; Jansen, G; Cloos, J
5516-Nov-2013Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: Analysis of clinical features and outcomes from the Asia Lymphoma study groupKim, S.J.; Jung, H.A.; Chuang, S.-S.; Hong, H.; Guo, C.-C.; Cao, J.; Hong, X.-N.; Suzuki, R.; Kang, H.J.; Won, J.H.; Chng, W.-J. ; Kwong, Y.-L.; Suh, C.; Song, Y.-Q.; Zhu, J.; Tay, K.; Lim, S.T.; Suzumiya, J.; Lin, T.-Y.; Kim, W.S.
562019EZH2 abnormalities in lymphoid malignancies: Underlying mechanisms and therapeutic implicationsLi, B. ; Chng, W.-J. 
5718-Aug-2016EZH2 phosphorylation by JAK3 mediates a switch to noncanonical function in natural killer/T-cell lymphomaYan, Junli; Li, Boheng ; Lin, Baohong; Lee, Pei Tsung ; Chung, Tae-Hoon; Tan, Joy; Bi, Chonglei; Lee, Xue Ting ; Selvarajan, Viknesvaran; Ng, Siok-Bian ; Yang, Henry ; Yu, Qiang; Chng, Wee-Joo 
5825-May-2022Fibrillary Glomerulonephritis and Monoclonal Gammopathy: Potential Diagnostic ChallengesDa, Yi; Goh, Giap Hean; Lau, Titus; Chng, Wee Joo ; Soekojo, Cinnie Yentia
5922-May-2020Frequent upregulation of G9a promotes RelB-dependent proliferation and survival in multiple myelomaZhang, X.Y.; Rajagopalan, D. ; Chung, T.-H. ; Hooi, L. ; Toh, T.B. ; Tian, J.S. ; Rashid, M.B.M.A.; Sahib, N.R.B.M. ; Gu, M.; Lim, J.J. ; Wang, W. ; Chng, W.J. ; Jha, S. ; Chow, E.K.-H. 
602015Functional characterization of D9, a novel deazaneplanocin a (DZNep) analog, in targeting acute myeloid leukemia (AML)Jiang, Xia; Lim, Cheryl Zi Hui; Li, Zhimei; Lee, Puayleng; Yatim, Siti Maryam J. M.; Guan, Peiyong; Li, Juntao; Zhou, Jianbiao ; Pan, Jingxuan; Chng, Wee Joo ; Chai, Li Lin Christina ; Yu, Qiang